ABSTRACT
Introduction To discover trends and patterns of opioid poisoning and the demographic and regional disparities by analyzing large scale patient visits data in New York State (NYS).
Methods Demographic, spatial, temporal and correlation analyses were performed for all OP patients extracted from the New York Statewide Planning and Research Cooperative System (SPARCS) from 2010 to 2016, along with Decennial US Census and American Community Survey zip code level data. The study is based on claims data. 58,481 patients with at least one OP diagnosis and a valid NYS zip code address were included. OP patient counts and rates per 100,000 population; patient level factors (gender, age, race and ethnicity, residential zip code); zip code level social demographic factors. Analyses were completed between 2017 and 2019.
Results In this study of 58,481 patients with opioid poisoning (OP) in New York State from 2010 to 2016, the OP rate increased by 364.6%, and by 741.5% for the age group > 65 years. There were wide disparities among groups by race and ethnicity on rates and age distributions of OP. Heroin and non-Heroin based OP rates show distinct temporal trends as well as major geospatial variation.
Conclusions The findings highlight strong demographic disparity of OP patients, evolving patterns and substantial geospatial variation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported in part by National Science Foundation ACI 1443054 and by NSF IIS 1350885, and Stony Brook University OVPR Seed Grant. The authors disclose no conflicts of interest. The study funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Institutional Review Board of Stony Brook University, and the Office of Quality and Patient Safety, Department of Health of New York State.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data is from New York Statewide Planning and Research Cooperative System (SPARCS) which is available for research purposes upon request and approval.
